The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.

 
Web www.patentalert.com

< Diagnosis and treatment of inflammation and hyperactive immune conditions

< Quinolinones and uses thereof

> Amino acid sequences capable of facilitating penetration across a biological barrier

> Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
~ 00248